# Combining Varenicline and Bupropion for Smoking Cessation

> **NCT00943618** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 641 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Bupropion
- **OTHER:** Placebo
- **BEHAVIORAL:** Counseling/Phone Calls

## Key facts

- **NCT ID:** NCT00943618
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-17
- **Primary completion:** 2020-05-31
- **Final completion:** 2021-09-09
- **Target enrollment:** 641 (ACTUAL)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943618, "Combining Varenicline and Bupropion for Smoking Cessation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00943618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*